Envision Pharma Group (Envision) has appointed Alice Choi as President, Integrated Medical Capabilities and Solutions (IMC) and member of its Executive Leadership Team.
In her new role, Alice will lead the organization’s IMC division made up of experts in medical strategy, medical communications, publications planning and delivery, patient engagement, and more to deliver smarter, faster outcomes for life sciences clients.
“I am so pleased to welcome Alice to the Envision team and her invaluable experience as a global life sciences industry leader,” shares Howard Miller, CEO of Envision Pharma Group. “Alice brings a depth of strategic expertise, knowledge, and insight in the medical communications, scientific research, and publications field that will be instrumental in propelling our vision forward for our people and serving the needs of our clients.”
Alice joins Envision from IPG Health where she most recently served as EVP, Managing Director, Client Solutions, APAC. Prior to this, the bulk of her career was in IPG Health Medical Communications – latterly as Chief Operating Officer for the group and formerly, as Head of Complete Medical Communications. During her tenure, she played a pivotal role in establishing and fulfilling long-term business goals while focusing on building upon key client relationships to foster sustained business growth, development, and operational excellence across several global teams.
Alice is committed to best practices and standards in medical communications, as demonstrated through her success at IPG Health Medical Communications and also her current role as Chair of the Healthcare Communications Association, and former tenure as Chair of the International Society of Medical Publications Professionals (ISMPP).
Alice adds, “I have long admired the work done by Envision and am excited to be joining such a stellar team. Medical communications continue to move at a rapid pace, and I am looking forward to ensuring that we continue to lead the field in terms of our people, our quality, and our innovative patient-centric services.”